Author Affiliations: West China School of Nursing, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Woman and Children, Sichuan University, Ministry of Education, West China Second University Hospital (Ms Bai and Mrs Zuo); West China School of Nursing, Sichuan University/West China Hospital Sichuan University (Mrs Huang); and Key Laboratory of Birth Defects and Related Diseases of Woman and Children, Sichuan University, Ministry of Education, West China Second University Hospital, Sichuan, China (Mrs Yao).
Cancer Nurs. 2024;47(4):307-318. doi: 10.1097/NCC.0000000000001198. Epub 2023 Feb 16.
The literature is inconsistent on the prevalence and risk factors of urinary retention in patients with cervical cancer.
The aim of this study was to review the literature on the prevalence of urinary retention in patients with cervical cancer and consolidate the risk factors.
For this meta-analysis, eligible articles published in English or Chinese by December 10, 2021, were systematically searched for and retrieved from PubMed, Cochrane Library, Ovid-Embase Medline, Web of Science, PsycINFO, CINAHL, and Scopus. Prevalence, odds ratios (ORs), and 95% confidence intervals (CIs) were used for meta-analysis.
Twenty-five studies were included in the analysis. The pooled overall prevalence was 0.26 (95% CI, 0.21-0.30, I2 = 95.0%). The identified risk factors were age (OR, 1.13; 95% CI, 1.08-1.19), urinary tract infection (UTI) (OR, 3.33; 95% CI, 1.48-7.49), surgical extent (OR, 2.95; 95% CI, 1.27-6.85), and catheter indwelling time (OR, 3.44; 95% CI, 2.43-3.87).
The prevalence of urinary retention in patients with cervical cancer is 0.26. Older age, UTI, longer catheter indwelling time, and a larger surgical extent may increase the risk of urinary retention. Clinicians should identify patients at risk and adopt interventions such as individualized catheter care.
Nursing staff should assess the risk of urinary retention in a patient with cervical cancer according to her age, presence of UTI, surgical extent, and catheterization time. A carefully chosen surgical procedure and interventions such as individualized education, timely catheter removal, treatment of UTI, and rehabilitation should be offered.
文献中关于宫颈癌患者尿潴留的患病率和相关风险因素并不一致。
本研究旨在回顾宫颈癌患者尿潴留的文献，对其患病率进行分析，并对相关风险因素进行整合。
本荟萃分析检索了 2021 年 12 月 10 日之前发表的英文和中文文献，检索数据库包括 PubMed、Cochrane 图书馆、Ovid-Embase Medline、Web of Science、PsycINFO、CINAHL 和 Scopus。使用患病率、比值比（OR）及其 95%置信区间（CI）进行荟萃分析。
共纳入 25 项研究。汇总的总体患病率为 0.26（95%CI，0.21-0.30，I2=95.0%）。确定的风险因素包括年龄（OR，1.13；95%CI，1.08-1.19）、尿路感染（UTI）（OR，3.33；95%CI，1.48-7.49）、手术范围（OR，2.95；95%CI，1.27-6.85）和导尿管留置时间（OR，3.44；95%CI，2.43-3.87）。
宫颈癌患者尿潴留的患病率为 0.26。年龄较大、UTI、导尿管留置时间较长以及手术范围较大可能会增加尿潴留的风险。临床医生应识别出有风险的患者，并采取个体化导尿管护理等干预措施。
护理人员应根据宫颈癌患者的年龄、是否存在 UTI、手术范围和导尿时间评估其发生尿潴留的风险。应选择合适的手术方式，并提供个体化教育、及时拔除导尿管、治疗 UTI、康复等干预措施。
